NCT04624256 2026-03-13
GARUDA
Jonsson Comprehensive Cancer Center
Phase NA Active not recruiting
Clinical Trials
15 trialsNCT01266642 2026-03-11
Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT04454528 2026-03-10
BreastVAX
Abramson Cancer Center at Penn Medicine
Phase 1/2 Active not recruiting
NCT04708067 2026-03-05
Hypofractionated Radiation Therapy and Bintrafusp Alfa for the Treatment of Advanced Intrahepatic Cholangiocarcinoma
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
NCT03796767 2026-01-28
SOAR
University of Utah
Phase 2 Active not recruiting
NCT02912312 2026-01-07
Hypofractionated vs. Conventional Regional Nodal Radiation Therapy for Patients With Invasive Breast Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT03987386 2025-11-12
Conventional or Hypofractionated Radiation Therapy in Treating Patients With Prostate Cancer
M.D. Anderson Cancer Center
Phase 3 Active not recruiting
NCT06443359 2025-06-11
Hypofractionated Regional Nodal Irradiation in Breast Cancer
Corewell Health East
Phase NA Active not recruiting
NCT04106856 2025-04-06
SHAPER
University of Utah
Phase 1 Active not recruiting
NCT03972930 2025-01-17
Hypofractionated Radiotherapy for Soft Tissue Sarcomas
University of Wisconsin, Madison
Phase 2 Active not recruiting
NCT01444820 2024-12-04
Hypofractionated, Dose Escalation Radiotherapy for High Risk Adenocarcinoma of the Prostate
Sir Mortimer B. Davis - Jewish General Hospital
Phase 3 Active not recruiting
NCT05139368 2024-11-18
RT-PACE
University of Utah
Phase NA Active not recruiting
NCT01985087 2024-10-31
A Study Using Radiation Therapy and Temozolomide to Treat Glioblastoma in Patients Over 70
University of Louisville
Phase 1/2 Active not recruiting
NCT03486821 2024-09-19
Ultra-hypofractionated Radiation in Prostate Cancer
University of Kansas Medical Center
Phase NA Active not recruiting
NCT03127995 2024-04-09
HYPOG-01
UNICANCER
Phase NA Active not recruiting